ImmunityBio, Inc.

IBRX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001326110

SEC filings (opens in a new tab)

No open-market purchases or sales by ImmunityBio, Inc. insiders were filed in the last 90 days; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding ImmunityBio, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of IBRX: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Of which not filed for Q1 2024	Q1 2024	Change
Holders	148	1	166	+19
Shares	57.5M	534.2K	66.4M	+9.40M (+16.5%)
Value	$288.9M	$2.68M	$356.9M	+$70.7M (+24.7%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held ImmunityBio, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to IBRX in Q1 2024
Institution	Shares	Value	% of portfolio
Perceptive Advisors LLC	1,052,887	$5.65M	0.10%
Franklin Resources Inc	391,752	$2.10M	0.00%
Skandinaviska Enskilda Banken AB (publ)	270,950	$1.46M	0.01%
Toroso Investments, LLC	92,839	$498.5K	0.01%
National Bank of Canada	55,311	$449.1K	0.00%
Caption Management, LLC	73,654	$395.5K	0.04%
Ensign Peak Advisors, Inc	59,650	$320.3K	0.00%
Cubist Systematic Strategies, LLC	56,968	$305.9K	0.00%
Dark Forest Capital Management LP	45,433	$244.0K	0.04%
Marex Group plc	37,800	$203.0K	0.01%
XTX Topco Ltd	36,427	$195.6K	0.03%
Panagora Asset Management Inc	27,279	$146.5K	0.00%
Raymond James & Associates	23,413	$125.7K	0.00%
GTS Securities LLC	20,467	$109.9K	0.00%
AQR Capital Management LLC	18,725	$100.6K	0.00%
Brookstone Capital Management	18,715	$100.5K	0.00%
Aigen Investment Management, LP	16,131	$86.6K	0.02%
Axxcess Wealth Management, LLC	15,800	$84.8K	0.00%
SEI Investments Co	13,772	$74.0K	0.00%
Wolverine Trading, LLC	13,303	$71.4K	0.00%
Sigma Planning Corp	12,920	$69.4K	0.00%
Simplicity Wealth,LLC	10,823	$58.1K	0.00%
Bleakley Financial Group, LLC	10,823	$58.1K	0.00%
HSBC Holdings PLC	10,546	$56.6K	0.00%
HighTower Advisors, LLC	10,302	$55.0K	0.00%
Pacer Advisors, Inc.	6,097	$32.7K	0.00%
Jones Financial Companies LLLP	3,000	$16.1K	0.00%
GAMMA Investing LLC	117	$628	0.00%
Citadel Advisors LLC	48	$258	0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	26	$139	0.00%
Rothschild Investment LLC	25	$134	0.00%
Investors Research Corp	15	$81	0.00%
SJS Investment Consulting Inc.	11	$60	0.00%
JFS Wealth Advisors, LLC	10	$54	0.00%
DiNuzzo Private Wealth, Inc.	3	$17	0.00%

Sold out (16)

Institutions that held ImmunityBio, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of IBRX in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
New York Life Investment Management LLC	191,221	$959.9K
Fishman Jay A Ltd	145,600	$730.9K
Squarepoint Ops LLC	55,322	$277.7K
Simplex Trading, LLC	52,314	$262.0K
SG Americas Securities, LLC	49,005	$246.0K
Liberty One Investment Management, LLC	47,687	$239.4K
Two Sigma Securities, LLC	43,604	$218.9K
Stratos Wealth Partners, LTD.	34,050	$170.9K
ExodusPoint Capital Management, LP	23,558	$118.0K
Western Wealth Management, LLC	20,470	$102.8K
Compagnie Lombard Odier SCmA	14,000	$70.3K
Integrated Wealth Concepts LLC	13,508	$67.8K
Axq Capital, LP	12,400	$62.2K
Advisory Services Network, LLC	2,506	$12.6K
Mayo Clinic	1,403	$7.04K
Cutler Group LP	86	$0

Not filed for Q1 2024 yet (1)

Institutions that held ImmunityBio, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q4 2023 that haven't filed for Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Putnam Investments LLC	534,201	$2.68M